<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1991-05-01" modified="2017-10-25" version="200">
<accession>P21675</accession>
<accession>A5CVC8</accession>
<accession>A5CVC9</accession>
<accession>A5CVD0</accession>
<accession>A5CVD1</accession>
<accession>B1Q2X3</accession>
<accession>Q59FZ3</accession>
<accession>Q6IUZ1</accession>
<accession>Q70Q86</accession>
<accession>Q70Q87</accession>
<accession>Q70T00</accession>
<accession>Q70T01</accession>
<accession>Q70T02</accession>
<accession>Q70T03</accession>
<name>TAF1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Transcription initiation factor TFIID subunit 1</fullName>
<ecNumber evidence="18">2.3.1.48</ecNumber>
<ecNumber>2.7.11.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Cell cycle gene 1 protein</fullName>
</alternativeName>
<alternativeName>
<fullName>TBP-associated factor 250 kDa</fullName>
<shortName>p250</shortName>
</alternativeName>
<alternativeName>
<fullName>Transcription initiation factor TFIID 250 kDa subunit</fullName>
<shortName>TAF(II)250</shortName>
<shortName>TAFII-250</shortName>
<shortName>TAFII250</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">TAF1</name>
<name type="synonym">BA2R</name>
<name type="synonym">CCG1</name>
<name type="synonym">CCGS</name>
<name type="synonym">TAF2A</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1991" name="Mol. Cell. Biol." volume="11" first="3317" last="3325">
<title>The human CCG1 gene, essential for progression of the G1 phase, encodes a 210-kilodalton nuclear DNA-binding protein.</title>
<authorList>
<person name="Sekiguchi T."/>
<person name="Nohiro Y."/>
<person name="Nakamura Y."/>
<person name="Hisamoto N."/>
<person name="Nishimoto T."/>
</authorList>
<dbReference type="PubMed" id="2038334"/>
<dbReference type="DOI" id="10.1128/MCB.11.6.3317"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<source>
<tissue>Laryngeal carcinoma</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1988" name="EMBO J." volume="7" first="1683" last="1687">
<title>Molecular cloning of the cDNA of human X chromosomal gene (CCG1) which complements the temperature-sensitive G1 mutants, tsBN462 and ts13, of the BHK cell line.</title>
<authorList>
<person name="Sekiguchi T."/>
<person name="Miyata T."/>
<person name="Nishimoto T."/>
</authorList>
<dbReference type="PubMed" id="3169001"/>
</citation>
<scope>PRELIMINARY NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1993" name="Nature" volume="362" first="175" last="179">
<title>Cloning and expression of human TAFII250: a TBP-associated factor implicated in cell-cycle regulation.</title>
<authorList>
<person name="Ruppert S."/>
<person name="Wang E.H."/>
<person name="Tjian R."/>
</authorList>
<dbReference type="PubMed" id="7680771"/>
<dbReference type="DOI" id="10.1038/362175a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>INTERACTION WITH TBP AND TAFS</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2007" name="Am. J. Hum. Genet." volume="80" first="393" last="406">
<title>Reduced neuron-specific expression of the TAF1 gene is associated with X-linked dystonia-parkinsonism.</title>
<authorList>
<person name="Makino S."/>
<person name="Kaji R."/>
<person name="Ando S."/>
<person name="Tomizawa M."/>
<person name="Yasuno K."/>
<person name="Goto S."/>
<person name="Matsumoto S."/>
<person name="Tabuena M.D."/>
<person name="Maranon E."/>
<person name="Dantes M."/>
<person name="Lee L.V."/>
<person name="Ogasawara K."/>
<person name="Tooyama I."/>
<person name="Akatsu H."/>
<person name="Nishimura M."/>
<person name="Tamiya G."/>
</authorList>
<dbReference type="PubMed" id="17273961"/>
<dbReference type="DOI" id="10.1086/512129"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM N-TAF1)</scope>
<scope>INVOLVEMENT IN DYT3</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2004-05" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT VAL-269</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2005" name="Nature" volume="434" first="325" last="337">
<title>The DNA sequence of the human X chromosome.</title>
<authorList>
<person name="Ross M.T."/>
<person name="Grafham D.V."/>
<person name="Coffey A.J."/>
<person name="Scherer S."/>
<person name="McLay K."/>
<person name="Muzny D."/>
<person name="Platzer M."/>
<person name="Howell G.R."/>
<person name="Burrows C."/>
<person name="Bird C.P."/>
<person name="Frankish A."/>
<person name="Lovell F.L."/>
<person name="Howe K.L."/>
<person name="Ashurst J.L."/>
<person name="Fulton R.S."/>
<person name="Sudbrak R."/>
<person name="Wen G."/>
<person name="Jones M.C."/>
<person name="Hurles M.E."/>
<person name="Andrews T.D."/>
<person name="Scott C.E."/>
<person name="Searle S."/>
<person name="Ramser J."/>
<person name="Whittaker A."/>
<person name="Deadman R."/>
<person name="Carter N.P."/>
<person name="Hunt S.E."/>
<person name="Chen R."/>
<person name="Cree A."/>
<person name="Gunaratne P."/>
<person name="Havlak P."/>
<person name="Hodgson A."/>
<person name="Metzker M.L."/>
<person name="Richards S."/>
<person name="Scott G."/>
<person name="Steffen D."/>
<person name="Sodergren E."/>
<person name="Wheeler D.A."/>
<person name="Worley K.C."/>
<person name="Ainscough R."/>
<person name="Ambrose K.D."/>
<person name="Ansari-Lari M.A."/>
<person name="Aradhya S."/>
<person name="Ashwell R.I."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Ballabio A."/>
<person name="Banerjee R."/>
<person name="Barker G.E."/>
<person name="Barlow K.F."/>
<person name="Barrett I.P."/>
<person name="Bates K.N."/>
<person name="Beare D.M."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Beck A."/>
<person name="Bethel G."/>
<person name="Blechschmidt K."/>
<person name="Brady N."/>
<person name="Bray-Allen S."/>
<person name="Bridgeman A.M."/>
<person name="Brown A.J."/>
<person name="Brown M.J."/>
<person name="Bonnin D."/>
<person name="Bruford E.A."/>
<person name="Buhay C."/>
<person name="Burch P."/>
<person name="Burford D."/>
<person name="Burgess J."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Bye J.M."/>
<person name="Carder C."/>
<person name="Carrel L."/>
<person name="Chako J."/>
<person name="Chapman J.C."/>
<person name="Chavez D."/>
<person name="Chen E."/>
<person name="Chen G."/>
<person name="Chen Y."/>
<person name="Chen Z."/>
<person name="Chinault C."/>
<person name="Ciccodicola A."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Clerc-Blankenburg K."/>
<person name="Clifford K."/>
<person name="Cobley V."/>
<person name="Cole C.G."/>
<person name="Conquer J.S."/>
<person name="Corby N."/>
<person name="Connor R.E."/>
<person name="David R."/>
<person name="Davies J."/>
<person name="Davis C."/>
<person name="Davis J."/>
<person name="Delgado O."/>
<person name="Deshazo D."/>
<person name="Dhami P."/>
<person name="Ding Y."/>
<person name="Dinh H."/>
<person name="Dodsworth S."/>
<person name="Draper H."/>
<person name="Dugan-Rocha S."/>
<person name="Dunham A."/>
<person name="Dunn M."/>
<person name="Durbin K.J."/>
<person name="Dutta I."/>
<person name="Eades T."/>
<person name="Ellwood M."/>
<person name="Emery-Cohen A."/>
<person name="Errington H."/>
<person name="Evans K.L."/>
<person name="Faulkner L."/>
<person name="Francis F."/>
<person name="Frankland J."/>
<person name="Fraser A.E."/>
<person name="Galgoczy P."/>
<person name="Gilbert J."/>
<person name="Gill R."/>
<person name="Gloeckner G."/>
<person name="Gregory S.G."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Grocock R."/>
<person name="Gu Y."/>
<person name="Gwilliam R."/>
<person name="Hamilton C."/>
<person name="Hart E.A."/>
<person name="Hawes A."/>
<person name="Heath P.D."/>
<person name="Heitmann K."/>
<person name="Hennig S."/>
<person name="Hernandez J."/>
<person name="Hinzmann B."/>
<person name="Ho S."/>
<person name="Hoffs M."/>
<person name="Howden P.J."/>
<person name="Huckle E.J."/>
<person name="Hume J."/>
<person name="Hunt P.J."/>
<person name="Hunt A.R."/>
<person name="Isherwood J."/>
<person name="Jacob L."/>
<person name="Johnson D."/>
<person name="Jones S."/>
<person name="de Jong P.J."/>
<person name="Joseph S.S."/>
<person name="Keenan S."/>
<person name="Kelly S."/>
<person name="Kershaw J.K."/>
<person name="Khan Z."/>
<person name="Kioschis P."/>
<person name="Klages S."/>
<person name="Knights A.J."/>
<person name="Kosiura A."/>
<person name="Kovar-Smith C."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leversha M."/>
<person name="Lewis L."/>
<person name="Liu W."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Loulseged H."/>
<person name="Loveland J.E."/>
<person name="Lovell J.D."/>
<person name="Lozado R."/>
<person name="Lu J."/>
<person name="Lyne R."/>
<person name="Ma J."/>
<person name="Maheshwari M."/>
<person name="Matthews L.H."/>
<person name="McDowall J."/>
<person name="McLaren S."/>
<person name="McMurray A."/>
<person name="Meidl P."/>
<person name="Meitinger T."/>
<person name="Milne S."/>
<person name="Miner G."/>
<person name="Mistry S.L."/>
<person name="Morgan M."/>
<person name="Morris S."/>
<person name="Mueller I."/>
<person name="Mullikin J.C."/>
<person name="Nguyen N."/>
<person name="Nordsiek G."/>
<person name="Nyakatura G."/>
<person name="O'dell C.N."/>
<person name="Okwuonu G."/>
<person name="Palmer S."/>
<person name="Pandian R."/>
<person name="Parker D."/>
<person name="Parrish J."/>
<person name="Pasternak S."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Pearson D.M."/>
<person name="Pelan S.E."/>
<person name="Perez L."/>
<person name="Porter K.M."/>
<person name="Ramsey Y."/>
<person name="Reichwald K."/>
<person name="Rhodes S."/>
<person name="Ridler K.A."/>
<person name="Schlessinger D."/>
<person name="Schueler M.G."/>
<person name="Sehra H.K."/>
<person name="Shaw-Smith C."/>
<person name="Shen H."/>
<person name="Sheridan E.M."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M.L."/>
<person name="Sotheran E.C."/>
<person name="Steingruber H.E."/>
<person name="Steward C.A."/>
<person name="Storey R."/>
<person name="Swann R.M."/>
<person name="Swarbreck D."/>
<person name="Tabor P.E."/>
<person name="Taudien S."/>
<person name="Taylor T."/>
<person name="Teague B."/>
<person name="Thomas K."/>
<person name="Thorpe A."/>
<person name="Timms K."/>
<person name="Tracey A."/>
<person name="Trevanion S."/>
<person name="Tromans A.C."/>
<person name="d'Urso M."/>
<person name="Verduzco D."/>
<person name="Villasana D."/>
<person name="Waldron L."/>
<person name="Wall M."/>
<person name="Wang Q."/>
<person name="Warren J."/>
<person name="Warry G.L."/>
<person name="Wei X."/>
<person name="West A."/>
<person name="Whitehead S.L."/>
<person name="Whiteley M.N."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams G."/>
<person name="Williams L."/>
<person name="Williamson A."/>
<person name="Williamson H."/>
<person name="Wilming L."/>
<person name="Woodmansey R.L."/>
<person name="Wray P.W."/>
<person name="Yen J."/>
<person name="Zhang J."/>
<person name="Zhou J."/>
<person name="Zoghbi H."/>
<person name="Zorilla S."/>
<person name="Buck D."/>
<person name="Reinhardt R."/>
<person name="Poustka A."/>
<person name="Rosenthal A."/>
<person name="Lehrach H."/>
<person name="Meindl A."/>
<person name="Minx P.J."/>
<person name="Hillier L.W."/>
<person name="Willard H.F."/>
<person name="Wilson R.K."/>
<person name="Waterston R.H."/>
<person name="Rice C.M."/>
<person name="Vaudin M."/>
<person name="Coulson A."/>
<person name="Nelson D.L."/>
<person name="Weinstock G."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Gibbs R.A."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="15772651"/>
<dbReference type="DOI" id="10.1038/nature03440"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-03" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
<person name="Ohara O."/>
<person name="Nagase T."/>
<person name="Kikuno R.F."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 837-1872 (ISOFORM 4)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2003" name="Proc. Natl. Acad. Sci. U.S.A." volume="100" first="10347" last="10352">
<title>Specific sequence changes in multiple transcript system DYT3 are associated with X-linked dystonia parkinsonism.</title>
<authorList>
<person name="Nolte D."/>
<person name="Niemann S."/>
<person name="Muller U."/>
</authorList>
<dbReference type="PubMed" id="12928496"/>
<dbReference type="DOI" id="10.1073/pnas.1831949100"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1347-1801 (ISOFORMS 2A; 2C AND 2D)</scope>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1347-1592 (ISOFORM 2E)</scope>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1498-1801 (ISOFORM 3)</scope>
<scope>INVOLVEMENT IN DYT3</scope>
<source>
<tissue>Fetal brain</tissue>
</source>
</reference>
<reference key="9">
<citation type="submission" date="2007-05" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Nolte D."/>
</authorList>
</citation>
<scope>SEQUENCE REVISION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2007" name="Mamm. Genome" volume="18" first="787" last="795">
<title>Structural and functional analysis of the human TAF1/DYT3 multiple transcript system.</title>
<authorList>
<person name="Herzfeld T."/>
<person name="Nolte D."/>
<person name="Muller U."/>
</authorList>
<dbReference type="PubMed" id="17952504"/>
<dbReference type="DOI" id="10.1007/s00335-007-9063-z"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1347-1801 (ISOFORMS 2E; 2G; 2H AND 2I)</scope>
<scope>ALTERNATIVE SPLICING</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1993" name="Nature" volume="362" first="179" last="181">
<title>The p250 subunit of native TATA box-binding factor TFIID is the cell-cycle regulatory protein CCG1.</title>
<authorList>
<person name="Hisatake K."/>
<person name="Hasegawa S."/>
<person name="Takada R."/>
<person name="Nakatani Y."/>
<person name="Horikoshi M."/>
<person name="Roeder R.G."/>
</authorList>
<dbReference type="PubMed" id="8450888"/>
<dbReference type="DOI" id="10.1038/362179a0"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1996" name="Cell" volume="84" first="781" last="790">
<title>TAFII250 is a bipartite protein kinase that phosphorylates the base transcription factor RAP74.</title>
<authorList>
<person name="Dikstein R."/>
<person name="Ruppert S."/>
<person name="Tjian R."/>
</authorList>
<dbReference type="PubMed" id="8625415"/>
<dbReference type="DOI" id="10.1016/S0092-8674(00)81055-7"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT SER-137 AND SER-307</scope>
<scope>ATP-BINDING</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1996" name="Genes Dev." volume="10" first="1369" last="1381">
<title>TAF-like function of SV40 large T antigen.</title>
<authorList>
<person name="Damania B."/>
<person name="Alwine J.C."/>
</authorList>
<dbReference type="PubMed" id="8647434"/>
<dbReference type="DOI" id="10.1101/gad.10.11.1369"/>
</citation>
<scope>INTERACTION WITH SV40 LARGE T ANTIGEN</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1996" name="Mol. Cell. Biol." volume="16" first="3085" last="3093">
<title>Interaction of the viral activator protein ICP4 with TFIID through TAF250.</title>
<authorList>
<person name="Carrozza M.J."/>
<person name="DeLuca N.A."/>
</authorList>
<dbReference type="PubMed" id="8649420"/>
<dbReference type="DOI" id="10.1128/MCB.16.6.3085"/>
</citation>
<scope>INTERACTION WITH HERPES SIMPLEX VIRUS 1 ICP4</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1998" name="Mol. Cell" volume="1" first="905" last="911">
<title>Functional analysis of the human TAFII250 N-terminal kinase domain.</title>
<authorList>
<person name="O'Brien T."/>
<person name="Tjian R."/>
</authorList>
<dbReference type="PubMed" id="9660973"/>
<dbReference type="DOI" id="10.1016/S1097-2765(00)80089-1"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="846" last="854">
<title>Rb inhibits the intrinsic kinase activity of TATA-binding protein-associated factor TAFII250.</title>
<authorList>
<person name="Siegert J.L."/>
<person name="Robbins P.D."/>
</authorList>
<dbReference type="PubMed" id="9858607"/>
<dbReference type="DOI" id="10.1128/MCB.19.1.846"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RB1</scope>
<scope>ATP-BINDING</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2000" name="Genes Cells" volume="5" first="221" last="233">
<title>A human homologue of yeast anti-silencing factor has histone chaperone activity.</title>
<authorList>
<person name="Munakata T."/>
<person name="Adachi N."/>
<person name="Yokoyama N."/>
<person name="Kuzuhara T."/>
<person name="Horikoshi M."/>
</authorList>
<dbReference type="PubMed" id="10759893"/>
<dbReference type="DOI" id="10.1046/j.1365-2443.2000.00319.x"/>
</citation>
<scope>INTERACTION WITH ASF1A</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="15886" last="15892">
<title>Taf(II) 250 phosphorylates human transcription factor IIA on serine residues important for TBP binding and transcription activity.</title>
<authorList>
<person name="Solow S."/>
<person name="Salunek M."/>
<person name="Ryan R."/>
<person name="Lieberman P.M."/>
</authorList>
<dbReference type="PubMed" id="11278496"/>
<dbReference type="DOI" id="10.1074/jbc.M009385200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="9334" last="9339">
<title>Identification and characterization of CIA/ASF1 as an interactor of bromodomains associated with TFIID.</title>
<authorList>
<person name="Chimura T."/>
<person name="Kuzuhara T."/>
<person name="Horikoshi M."/>
</authorList>
<dbReference type="PubMed" id="12093919"/>
<dbReference type="DOI" id="10.1073/pnas.142627899"/>
</citation>
<scope>INTERACTION WITH ASF1A</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="35660" last="35667">
<title>Transcription initiation factor IID-interactive histone chaperone CIA-II implicated in mammalian spermatogenesis.</title>
<authorList>
<person name="Umehara T."/>
<person name="Horikoshi M."/>
</authorList>
<dbReference type="PubMed" id="12842904"/>
<dbReference type="DOI" id="10.1074/jbc.M303549200"/>
</citation>
<scope>INTERACTION WITH ASF1A AND ASF1B</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2004" name="Mol. Cell" volume="13" first="867" last="878">
<title>Phosphorylation on Thr-55 by TAF1 mediates degradation of p53: a role for TAF1 in cell G1 progression.</title>
<authorList>
<person name="Li H.-H."/>
<person name="Li A.G."/>
<person name="Sheppard H.M."/>
<person name="Liu X."/>
</authorList>
<dbReference type="PubMed" id="15053879"/>
<dbReference type="DOI" id="10.1016/S1097-2765(04)00123-6"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH TP53</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2005" name="Cell" volume="121" first="873" last="885">
<title>Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF.</title>
<authorList>
<person name="Dou Y."/>
<person name="Milne T.A."/>
<person name="Tackett A.J."/>
<person name="Smith E.R."/>
<person name="Fukuda A."/>
<person name="Wysocka J."/>
<person name="Allis C.D."/>
<person name="Chait B.T."/>
<person name="Hess J.L."/>
<person name="Roeder R.G."/>
</authorList>
<dbReference type="PubMed" id="15960975"/>
<dbReference type="DOI" id="10.1016/j.cell.2005.04.031"/>
</citation>
<scope>IDENTIFICATION IN THE MLL1/MLL COMPLEX</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2005" name="Mol. Cell. Biol." volume="25" first="4321" last="4332">
<title>TAF1 histone acetyltransferase activity in Sp1 activation of the cyclin D1 promoter.</title>
<authorList>
<person name="Hilton T.L."/>
<person name="Li Y."/>
<person name="Dunphy E.L."/>
<person name="Wang E.H."/>
</authorList>
<dbReference type="PubMed" id="15870300"/>
<dbReference type="DOI" id="10.1128/MCB.25.10.4321-4332.2005"/>
</citation>
<scope>HISTONE ACETYLTRANSFERASE ACTIVITY</scope>
<scope>MUTAGENESIS OF GLU-721 AND 827-MET--ASP-829</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1826</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1700 (ISOFORMS 2A AND 4)</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1702 (ISOFORM 2G)</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1697 (ISOFORM 3)</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2012" name="Mol. Cell. Biol." volume="32" first="3358" last="3369">
<title>Phosphorylation-dependent regulation of cyclin D1 and cyclin A gene transcription by TFIID subunits TAF1 and TAF7.</title>
<authorList>
<person name="Kloet S.L."/>
<person name="Whiting J.L."/>
<person name="Gafken P."/>
<person name="Ranish J."/>
<person name="Wang E.H."/>
</authorList>
<dbReference type="PubMed" id="22711989"/>
<dbReference type="DOI" id="10.1128/MCB.00416-12"/>
</citation>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2013" name="Hum. Mol. Genet." volume="22" first="941" last="951">
<title>X-linked dystonia parkinsonism syndrome (XDP, lubag): disease-specific sequence change DSC3 in TAF1/DYT3 affects genes in vesicular transport and dopamine metabolism.</title>
<authorList>
<person name="Herzfeld T."/>
<person name="Nolte D."/>
<person name="Grznarova M."/>
<person name="Hofmann A."/>
<person name="Schultze J.L."/>
<person name="Muller U."/>
</authorList>
<dbReference type="PubMed" id="23184149"/>
<dbReference type="DOI" id="10.1093/hmg/dds499"/>
</citation>
<scope>MISCELLANEOUS</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-307</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-549 AND LYS-562</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2000" name="Science" volume="288" first="1422" last="1425">
<title>Structure and function of a human TAFII250 double bromodomain module.</title>
<authorList>
<person name="Jacobson R.H."/>
<person name="Ladurner A.G."/>
<person name="King D.S."/>
<person name="Tjian R."/>
</authorList>
<dbReference type="PubMed" id="10827952"/>
<dbReference type="DOI" id="10.1126/science.288.5470.1422"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 1359-1638</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2012" name="Cell" volume="149" first="214" last="231">
<title>Histone recognition and large-scale structural analysis of the human bromodomain family.</title>
<authorList>
<person name="Filippakopoulos P."/>
<person name="Picaud S."/>
<person name="Mangos M."/>
<person name="Keates T."/>
<person name="Lambert J.P."/>
<person name="Barsyte-Lovejoy D."/>
<person name="Felletar I."/>
<person name="Volkmer R."/>
<person name="Muller S."/>
<person name="Pawson T."/>
<person name="Gingras A.C."/>
<person name="Arrowsmith C.H."/>
<person name="Knapp S."/>
</authorList>
<dbReference type="PubMed" id="22464331"/>
<dbReference type="DOI" id="10.1016/j.cell.2012.02.013"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.89 ANGSTROMS) OF 1501-1635</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2014" name="Cell Res." volume="24" first="1433" last="1444">
<title>Crystal structure of a TAF1-TAF7 complex in human transcription factor IID reveals a promoter binding module.</title>
<authorList>
<person name="Wang H."/>
<person name="Curran E.C."/>
<person name="Hinds T.R."/>
<person name="Wang E.H."/>
<person name="Zheng N."/>
</authorList>
<dbReference type="PubMed" id="25412659"/>
<dbReference type="DOI" id="10.1038/cr.2014.148"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 579-1215 IN COMPLEX WITH TAF7</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH TAF7</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2015" name="Structure" volume="23" first="1801" last="1814">
<title>A subset of human bromodomains recognizes butyryllysine and crotonyllysine histone peptide modifications.</title>
<authorList>
<person name="Flynn E.M."/>
<person name="Huang O.W."/>
<person name="Poy F."/>
<person name="Oppikofer M."/>
<person name="Bellon S.F."/>
<person name="Tang Y."/>
<person name="Cochran A.G."/>
</authorList>
<dbReference type="PubMed" id="26365797"/>
<dbReference type="DOI" id="10.1016/j.str.2015.08.004"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.50 ANGSTROMS) OF 1497-1638 IN COMPLEX WITH CROTONYLATED OR BUTYRYLATED HISTONE H4</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2016" name="Nature" volume="531" first="604" last="609">
<title>Structure of promoter-bound TFIID and model of human pre-initiation complex assembly.</title>
<authorList>
<person name="Louder R.K."/>
<person name="He Y."/>
<person name="Lopez-Blanco J.R."/>
<person name="Fang J."/>
<person name="Chacon P."/>
<person name="Nogales E."/>
</authorList>
<dbReference type="PubMed" id="27007846"/>
<dbReference type="DOI" id="10.1038/nature17394"/>
</citation>
<scope>STRUCTURE BY ELECTRON MICROSCOPY (8.50 ANGSTROMS)</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] VAL-269; GLY-297; ASP-453; LYS-651 AND ILE-691</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2015" name="Am. J. Hum. Genet." volume="97" first="922" last="932">
<title>TAF1 Variants Are Associated with Dysmorphic Features, Intellectual Disability, and Neurological Manifestations.</title>
<authorList>
<person name="O'Rawe J.A."/>
<person name="Wu Y."/>
<person name="Doerfel M.J."/>
<person name="Rope A.F."/>
<person name="Au P.Y."/>
<person name="Parboosingh J.S."/>
<person name="Moon S."/>
<person name="Kousi M."/>
<person name="Kosma K."/>
<person name="Smith C.S."/>
<person name="Tzetis M."/>
<person name="Schuette J.L."/>
<person name="Hufnagel R.B."/>
<person name="Prada C.E."/>
<person name="Martinez F."/>
<person name="Orellana C."/>
<person name="Crain J."/>
<person name="Caro-Llopis A."/>
<person name="Oltra S."/>
<person name="Monfort S."/>
<person name="Jimenez-Barron L.T."/>
<person name="Swensen J."/>
<person name="Ellingwood S."/>
<person name="Smith R."/>
<person name="Fang H."/>
<person name="Ospina S."/>
<person name="Stegmann S."/>
<person name="Den Hollander N."/>
<person name="Mittelman D."/>
<person name="Highnam G."/>
<person name="Robison R."/>
<person name="Yang E."/>
<person name="Faivre L."/>
<person name="Roubertie A."/>
<person name="Riviere J.B."/>
<person name="Monaghan K.G."/>
<person name="Wang K."/>
<person name="Davis E.E."/>
<person name="Katsanis N."/>
<person name="Kalscheuer V.M."/>
<person name="Wang E.H."/>
<person name="Metcalfe K."/>
<person name="Kleefstra T."/>
<person name="Innes A.M."/>
<person name="Kitsiou-Tzeli S."/>
<person name="Rosello M."/>
<person name="Keegan C.E."/>
<person name="Lyon G.J."/>
</authorList>
<dbReference type="PubMed" id="26637982"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2015.11.005"/>
</citation>
<scope>INVOLVEMENT IN MRXS33</scope>
<scope>VARIANTS MRXS33 SER-575; ARG-786; HIS-955; TRP-1225; THR-1316; HIS-1431 AND HIS-1496</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2016" name="Mol. Psychiatry" volume="21" first="133" last="148">
<title>X-exome sequencing of 405 unresolved families identifies seven novel intellectual disability genes.</title>
<authorList>
<person name="Hu H."/>
<person name="Haas S.A."/>
<person name="Chelly J."/>
<person name="Van Esch H."/>
<person name="Raynaud M."/>
<person name="de Brouwer A.P."/>
<person name="Weinert S."/>
<person name="Froyen G."/>
<person name="Frints S.G."/>
<person name="Laumonnier F."/>
<person name="Zemojtel T."/>
<person name="Love M.I."/>
<person name="Richard H."/>
<person name="Emde A.K."/>
<person name="Bienek M."/>
<person name="Jensen C."/>
<person name="Hambrock M."/>
<person name="Fischer U."/>
<person name="Langnick C."/>
<person name="Feldkamp M."/>
<person name="Wissink-Lindhout W."/>
<person name="Lebrun N."/>
<person name="Castelnau L."/>
<person name="Rucci J."/>
<person name="Montjean R."/>
<person name="Dorseuil O."/>
<person name="Billuart P."/>
<person name="Stuhlmann T."/>
<person name="Shaw M."/>
<person name="Corbett M.A."/>
<person name="Gardner A."/>
<person name="Willis-Owen S."/>
<person name="Tan C."/>
<person name="Friend K.L."/>
<person name="Belet S."/>
<person name="van Roozendaal K.E."/>
<person name="Jimenez-Pocquet M."/>
<person name="Moizard M.P."/>
<person name="Ronce N."/>
<person name="Sun R."/>
<person name="O'Keeffe S."/>
<person name="Chenna R."/>
<person name="van Boemmel A."/>
<person name="Goeke J."/>
<person name="Hackett A."/>
<person name="Field M."/>
<person name="Christie L."/>
<person name="Boyle J."/>
<person name="Haan E."/>
<person name="Nelson J."/>
<person name="Turner G."/>
<person name="Baynam G."/>
<person name="Gillessen-Kaesbach G."/>
<person name="Mueller U."/>
<person name="Steinberger D."/>
<person name="Budny B."/>
<person name="Badura-Stronka M."/>
<person name="Latos-Bielenska A."/>
<person name="Ousager L.B."/>
<person name="Wieacker P."/>
<person name="Rodriguez Criado G."/>
<person name="Bondeson M.L."/>
<person name="Anneren G."/>
<person name="Dufke A."/>
<person name="Cohen M."/>
<person name="Van Maldergem L."/>
<person name="Vincent-Delorme C."/>
<person name="Echenne B."/>
<person name="Simon-Bouy B."/>
<person name="Kleefstra T."/>
<person name="Willemsen M."/>
<person name="Fryns J.P."/>
<person name="Devriendt K."/>
<person name="Ullmann R."/>
<person name="Vingron M."/>
<person name="Wrogemann K."/>
<person name="Wienker T.F."/>
<person name="Tzschach A."/>
<person name="van Bokhoven H."/>
<person name="Gecz J."/>
<person name="Jentsch T.J."/>
<person name="Chen W."/>
<person name="Ropers H.H."/>
<person name="Kalscheuer V.M."/>
</authorList>
<dbReference type="PubMed" id="25644381"/>
<dbReference type="DOI" id="10.1038/mp.2014.193"/>
</citation>
<scope>VARIANTS ASP-472 AND CYS-1169</scope>
</reference>
<comment type="function">
<text evidence="13 17 18 22 25 29 31 32 35 36">Largest component and core scaffold of the TFIID basal transcription factor complex (PubMed:25412659, PubMed:27007846). Contains novel N- and C-terminal Ser/Thr kinase domains which can autophosphorylate or transphosphorylate other transcription factors. Phosphorylates TP53 on 'Thr-55' which leads to MDM2-mediated degradation of TP53. Phosphorylates GTF2A1 and GTF2F1 on Ser residues. Possesses DNA-binding activity (PubMed:25412659). Essential for progression of the G1 phase of the cell cycle (PubMed:11278496, PubMed:15053879, PubMed:2038334, PubMed:8450888, PubMed:8625415, PubMed:9660973, PubMed:9858607). Exhibits histone acetyltransferase activity towards histones H3 and H4 (PubMed:15870300).</text>
</comment>
<comment type="catalytic activity">
<text>ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="catalytic activity">
<text evidence="18">Acetyl-CoA + [protein]-L-lysine = CoA + [protein]-N(6)-acetyl-L-lysine.</text>
</comment>
<comment type="cofactor">
<cofactor>
<name>Mg(2+)</name>
<dbReference type="ChEBI" id="CHEBI:18420"/>
</cofactor>
</comment>
<comment type="enzyme regulation">
<text evidence="24">Autophosphorylates on Ser residues. Inhibited by retinoblastoma tumor suppressor protein, RB1. Binding to TAF1 or CIITA inhibits the histone acetyltransferase activity.</text>
</comment>
<comment type="subunit">
<text evidence="12 14 15 17 19 23 25 29 30 33 34 36">TAF1 is the largest component of transcription factor TFIID that is composed of TBP and a variety of TBP-associated factors (PubMed:7680771). TAF1, when part of the TFIID complex, interacts with C-terminus of TP53 (PubMed:15053879). Part of a TFIID-containing RNA polymerase II pre-initiation complex that is composed of TBP and at least GTF2A1, GTF2A2, GTF2E1, GTF2E2, GTF2F1, GTF2H2, GTF2H3, GTF2H4, GTF2H5, GTF2B, TCEA1, ERCC2, ERCC3, TAF1, TAF2, TAF3, TAF4, TAF5, TAF6, TAF7, TAF8, TAF9, TAF10, TAF11, TAF12 and TAF13 (PubMed:27007846). Interacts with TAF7; the interaction is direct (PubMed:25412659). Component of some MLL1/MLL complex, at least composed of the core components KMT2A/MLL1, ASH2L, HCFC1/HCF1, WDR5 and RBBP5, as well as the facultative components BAP18, CHD8, E2F6, HSP70, INO80C, KANSL1, LAS1L, MAX, MCRS1, MGA, KAT8/MOF, PELP1, PHF20, PRP31, RING2, RUVB1/TIP49A, RUVB2/TIP49B, SENP3, TAF1, TAF4, TAF6, TAF7, TAF9 and TEX10. RB1 interacts with the N-terminal domain of TAF1. Interacts with ASF1A and ASF1B (PubMed:10759893, PubMed:12093919, PubMed:12842904). Interacts (via bromo domains) with acetylated lysine residues on the N-terminus of histone H1.4, H2A, H2B, H3 and H4 (in vitro) (PubMed:22464331). Interacts with SV40 Large T antigen (PubMed:8647434). Interacts with herpes simplex virus 1 ICP4 (PubMed:8649420).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491289"/>
<interactant intactId="EBI-2603114">
<id>P03255</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491289"/>
<interactant intactId="EBI-457886">
<id>P35269</id>
<label>GTF2F1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-491289"/>
<interactant intactId="EBI-355371">
<id>P20226</id>
<label>TBP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="22 29">Nucleus</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P21675-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P21675-2</id>
<name>2</name>
<sequence type="described" ref="VSP_012362"/>
</isoform>
<isoform>
<id>P21675-3</id>
<name>3</name>
<sequence type="described" ref="VSP_053382 VSP_053383 VSP_053384"/>
<text evidence="6">Contains a phosphoserine at position 1697.</text>
</isoform>
<isoform>
<id>P21675-4</id>
<name>4</name>
<sequence type="described" ref="VSP_053383"/>
<text evidence="6">Contains a phosphoserine at position 1700.</text>
</isoform>
<isoform>
<id>P21675-5</id>
<name>2a</name>
<sequence type="described" ref="VSP_053383 VSP_053384"/>
<text evidence="6">Contains a phosphoserine at position 1700.</text>
</isoform>
<isoform>
<id>P21675-6</id>
<name>2c</name>
<sequence type="described" ref="VSP_053384"/>
</isoform>
<isoform>
<id>P21675-7</id>
<name>2d</name>
<sequence type="described" ref="VSP_053381 VSP_053384"/>
</isoform>
<isoform>
<id>P21675-8</id>
<name>2e</name>
<name>2F</name>
<sequence type="described" ref="VSP_053379 VSP_053380"/>
</isoform>
<isoform>
<id>P21675-9</id>
<name>2g</name>
<sequence type="described" ref="VSP_053381 VSP_053383 VSP_053384"/>
<text evidence="6">Contains a phosphoserine at position 1702.</text>
</isoform>
<isoform>
<id>P21675-10</id>
<name>2h</name>
<sequence type="described" ref="VSP_053375 VSP_053377"/>
</isoform>
<isoform>
<id>P21675-11</id>
<name>2i</name>
<sequence type="described" ref="VSP_053376 VSP_053378"/>
</isoform>
<isoform>
<id>P21675-12</id>
<name>N-TAF1</name>
<name>TA14-391</name>
<sequence type="described" ref="VSP_012362 VSP_053381"/>
<text>Only detected in brain, highest expression in the caudate nucleus.</text>
</isoform>
<text>the TAF1/DYT3 multiple transcript system is composed of 38 evolutionary conserved exons plus 5 downstream exons referred to as exons d1-d5 that are primate-specific. Multiple highly polymorphic variants can be generated by splicing exons d3 and d4 to various combinations of exons 1-37.</text>
</comment>
<comment type="domain">
<text evidence="23 27">The Bromo domain mediates interaction with histones that have acetylated lysine residues at specific positions (PubMed:22464331). The second domain also recognizes and binds histones that are butyrylated and crotonylated (PubMed:26365797).</text>
</comment>
<comment type="PTM">
<text evidence="32">Phosphorylated by casein kinase II in vitro.</text>
</comment>
<comment type="disease" evidence="16 20">
<disease id="DI-00414">
<name>Dystonia 3, torsion, X-linked</name>
<acronym>DYT3</acronym>
<description>A X-linked dystonia-parkinsonism disorder. Dystonia is defined by the presence of sustained involuntary muscle contractions, often leading to abnormal postures. DYT3 is characterized by severe progressive torsion dystonia followed by parkinsonism. It has a well-defined pathology of extensive neuronal loss and mosaic gliosis in the striatum (caudate nucleus and putamen) which appears to resemble that in Huntington disease.</description>
<dbReference type="MIM" id="314250"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="28">
<disease id="DI-04617">
<name>Mental retardation, X-linked, syndromic, 33</name>
<acronym>MRXS33</acronym>
<description>A mental retardation syndrome characterized by intellectual deficit, delayed psychomotor development, delayed speech and language, and characteristic facial features. Mental retardation is defined by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period.</description>
<dbReference type="MIM" id="300966"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>Isoforms including the downstream (d) exons are preferentially expressed in brain, and may play a role in the regulation of genes involved in dopamine processing and transport.</text>
</comment>
<comment type="similarity">
<text evidence="42">Belongs to the TAF1 family.</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/taf1/"/>
</comment>
<dbReference type="EC" id="2.3.1.48" evidence="18"/>
<dbReference type="EC" id="2.7.11.1"/>
<dbReference type="EMBL" id="D90359">
<property type="protein sequence ID" value="BAA14374.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X07024">
<property type="protein sequence ID" value="CAA30073.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB300418">
<property type="protein sequence ID" value="BAG15901.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY623109">
<property type="protein sequence ID" value="AAT38105.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL590762">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL590763">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AB209316">
<property type="protein sequence ID" value="BAD92553.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ549247">
<property type="protein sequence ID" value="CAD70490.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ549248">
<property type="protein sequence ID" value="CAD70491.3"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ549249">
<property type="protein sequence ID" value="CAD70492.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ549250">
<property type="protein sequence ID" value="CAD70493.3"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ555148">
<property type="protein sequence ID" value="CAD87527.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ555149">
<property type="protein sequence ID" value="CAD87528.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AM711892">
<property type="protein sequence ID" value="CAM98555.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AM711893">
<property type="protein sequence ID" value="CAM98556.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AM711894">
<property type="protein sequence ID" value="CAM98557.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AM711895">
<property type="protein sequence ID" value="CAM98558.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS14412.1">
<molecule id="P21675-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS35325.1">
<molecule id="P21675-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS69783.1">
<molecule id="P21675-12"/>
</dbReference>
<dbReference type="PIR" id="A40262">
<property type="entry name" value="A40262"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001273003.1">
<molecule id="P21675-12"/>
<property type="nucleotide sequence ID" value="NM_001286074.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004597.2">
<molecule id="P21675-2"/>
<property type="nucleotide sequence ID" value="NM_004606.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_620278.1">
<molecule id="P21675-1"/>
<property type="nucleotide sequence ID" value="NM_138923.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005262354.1">
<molecule id="P21675-4"/>
<property type="nucleotide sequence ID" value="XM_005262297.4"/>
</dbReference>
<dbReference type="UniGene" id="Hs.158560"/>
<dbReference type="PDB" id="1EQF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=1359-1638"/>
</dbReference>
<dbReference type="PDB" id="3AAD">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A=1342-1629"/>
</dbReference>
<dbReference type="PDB" id="3UV4">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.89"/>
<property type="chains" value="A/B=1501-1635"/>
</dbReference>
<dbReference type="PDB" id="3UV5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.03"/>
<property type="chains" value="A=1373-1635"/>
</dbReference>
<dbReference type="PDB" id="4RGW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=579-1215"/>
</dbReference>
<dbReference type="PDB" id="4YYM">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A/B=1497-1638"/>
</dbReference>
<dbReference type="PDB" id="4YYN">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A/B=1497-1638"/>
</dbReference>
<dbReference type="PDB" id="5FUR">
<property type="method" value="EM"/>
<property type="resolution" value="8.50"/>
<property type="chains" value="G=1-1872"/>
</dbReference>
<dbReference type="PDB" id="5I1Q">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A=1497-1638"/>
</dbReference>
<dbReference type="PDB" id="5I29">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.21"/>
<property type="chains" value="A=1497-1638"/>
</dbReference>
<dbReference type="PDB" id="5MG2">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A=1501-1635"/>
</dbReference>
<dbReference type="PDBsum" id="1EQF"/>
<dbReference type="PDBsum" id="3AAD"/>
<dbReference type="PDBsum" id="3UV4"/>
<dbReference type="PDBsum" id="3UV5"/>
<dbReference type="PDBsum" id="4RGW"/>
<dbReference type="PDBsum" id="4YYM"/>
<dbReference type="PDBsum" id="4YYN"/>
<dbReference type="PDBsum" id="5FUR"/>
<dbReference type="PDBsum" id="5I1Q"/>
<dbReference type="PDBsum" id="5I29"/>
<dbReference type="PDBsum" id="5MG2"/>
<dbReference type="ProteinModelPortal" id="P21675"/>
<dbReference type="SMR" id="P21675"/>
<dbReference type="BioGrid" id="112735">
<property type="interactions" value="75"/>
</dbReference>
<dbReference type="CORUM" id="P21675"/>
<dbReference type="DIP" id="DIP-147N"/>
<dbReference type="IntAct" id="P21675">
<property type="interactions" value="38"/>
</dbReference>
<dbReference type="MINT" id="MINT-1211825"/>
<dbReference type="STRING" id="9606.ENSP00000276072"/>
<dbReference type="BindingDB" id="P21675"/>
<dbReference type="ChEMBL" id="CHEMBL3217390"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2231"/>
<dbReference type="iPTMnet" id="P21675"/>
<dbReference type="PhosphoSitePlus" id="P21675"/>
<dbReference type="BioMuta" id="TAF1"/>
<dbReference type="DMDM" id="115942"/>
<dbReference type="EPD" id="P21675"/>
<dbReference type="MaxQB" id="P21675"/>
<dbReference type="PaxDb" id="P21675"/>
<dbReference type="PeptideAtlas" id="P21675"/>
<dbReference type="PRIDE" id="P21675"/>
<dbReference type="Ensembl" id="ENST00000276072">
<molecule id="P21675-2"/>
<property type="protein sequence ID" value="ENSP00000276072"/>
<property type="gene ID" value="ENSG00000147133"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000373790">
<molecule id="P21675-1"/>
<property type="protein sequence ID" value="ENSP00000362895"/>
<property type="gene ID" value="ENSG00000147133"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000423759">
<molecule id="P21675-12"/>
<property type="protein sequence ID" value="ENSP00000406549"/>
<property type="gene ID" value="ENSG00000147133"/>
</dbReference>
<dbReference type="GeneID" id="6872"/>
<dbReference type="KEGG" id="hsa:6872"/>
<dbReference type="UCSC" id="uc004dzt.6">
<molecule id="P21675-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="6872"/>
<dbReference type="DisGeNET" id="6872"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000147133.15"/>
<dbReference type="GeneCards" id="TAF1"/>
<dbReference type="GeneReviews" id="TAF1"/>
<dbReference type="HGNC" id="HGNC:11535">
<property type="gene designation" value="TAF1"/>
</dbReference>
<dbReference type="HPA" id="CAB016283"/>
<dbReference type="HPA" id="HPA001075"/>
<dbReference type="MalaCards" id="TAF1"/>
<dbReference type="MIM" id="300966">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="313650">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="314250">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P21675"/>
<dbReference type="OpenTargets" id="ENSG00000147133"/>
<dbReference type="Orphanet" id="53351">
<property type="disease" value="X-linked dystonia-parkinsonism"/>
</dbReference>
<dbReference type="PharmGKB" id="PA36310"/>
<dbReference type="eggNOG" id="KOG0008">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG5076">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="eggNOG" id="COG5179">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000012659"/>
<dbReference type="HOGENOM" id="HOG000020066"/>
<dbReference type="HOVERGEN" id="HBG050223"/>
<dbReference type="InParanoid" id="P21675"/>
<dbReference type="KO" id="K03125"/>
<dbReference type="OMA" id="PTHMGPM"/>
<dbReference type="OrthoDB" id="EOG091G00MO"/>
<dbReference type="PhylomeDB" id="P21675"/>
<dbReference type="TreeFam" id="TF313573"/>
<dbReference type="Reactome" id="R-HSA-167161">
<property type="pathway name" value="HIV Transcription Initiation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167162">
<property type="pathway name" value="RNA Polymerase II HIV Promoter Escape"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167172">
<property type="pathway name" value="Transcription of the HIV genome"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-674695">
<property type="pathway name" value="RNA Polymerase II Pre-transcription Events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804756">
<property type="pathway name" value="Regulation of TP53 Activity through Phosphorylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-73776">
<property type="pathway name" value="RNA Polymerase II Promoter Escape"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-73779">
<property type="pathway name" value="RNA Polymerase II Transcription Pre-Initiation And Promoter Opening"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-75953">
<property type="pathway name" value="RNA Polymerase II Transcription Initiation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-76042">
<property type="pathway name" value="RNA Polymerase II Transcription Initiation And Promoter Clearance"/>
</dbReference>
<dbReference type="SIGNOR" id="P21675"/>
<dbReference type="EvolutionaryTrace" id="P21675"/>
<dbReference type="GeneWiki" id="TAF1"/>
<dbReference type="GenomeRNAi" id="6872"/>
<dbReference type="PRO" id="PR:P21675"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome X"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000147133"/>
<dbReference type="ExpressionAtlas" id="P21675">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P21675">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0071339">
<property type="term" value="C:MLL1 complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005667">
<property type="term" value="C:transcription factor complex"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005669">
<property type="term" value="C:transcription factor TFIID complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004402">
<property type="term" value="F:histone acetyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016301">
<property type="term" value="F:kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070577">
<property type="term" value="F:lysine-acetylated histone binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002039">
<property type="term" value="F:p53 binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000979">
<property type="term" value="F:RNA polymerase II core promoter sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001129">
<property type="term" value="F:RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0043565">
<property type="term" value="F:sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0017025">
<property type="term" value="F:TBP-class protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003713">
<property type="term" value="F:transcription coactivator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0061631">
<property type="term" value="F:ubiquitin conjugating enzyme activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007049">
<property type="term" value="P:cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0071318">
<property type="term" value="P:cellular response to ATP"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034644">
<property type="term" value="P:cellular response to UV"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006352">
<property type="term" value="P:DNA-templated transcription, initiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030901">
<property type="term" value="P:midbrain development"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010629">
<property type="term" value="P:negative regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1905524">
<property type="term" value="P:negative regulation of protein autoubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000059">
<property type="term" value="P:negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903026">
<property type="term" value="P:negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0018105">
<property type="term" value="P:peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0018107">
<property type="term" value="P:peptidyl-threonine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000825">
<property type="term" value="P:positive regulation of androgen receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032436">
<property type="term" value="P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032092">
<property type="term" value="P:positive regulation of protein binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045943">
<property type="term" value="P:positive regulation of transcription from RNA polymerase I promoter"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060261">
<property type="term" value="P:positive regulation of transcription initiation from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000209">
<property type="term" value="P:protein polyubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050821">
<property type="term" value="P:protein stabilization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042787">
<property type="term" value="P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902806">
<property type="term" value="P:regulation of cell cycle G1/S phase transition"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1901796">
<property type="term" value="P:regulation of signal transduction by p53 class mediator"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0010767">
<property type="term" value="P:regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060260">
<property type="term" value="P:regulation of transcription initiation from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051123">
<property type="term" value="P:RNA polymerase II transcriptional preinitiation complex assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006368">
<property type="term" value="P:transcription elongation from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0036369">
<property type="term" value="P:transcription factor catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006366">
<property type="term" value="P:transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006367">
<property type="term" value="P:transcription initiation from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.1100.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.20.920.10">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR001487">
<property type="entry name" value="Bromodomain"/>
</dbReference>
<dbReference type="InterPro" id="IPR036427">
<property type="entry name" value="Bromodomain-like_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR018359">
<property type="entry name" value="Bromodomain_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR011177">
<property type="entry name" value="TAF1_animal"/>
</dbReference>
<dbReference type="InterPro" id="IPR009067">
<property type="entry name" value="TAF_II_230-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR036741">
<property type="entry name" value="TAFII-230_TBP-bd_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR022591">
<property type="entry name" value="TFIID_sub1_DUF3591"/>
</dbReference>
<dbReference type="Pfam" id="PF00439">
<property type="entry name" value="Bromodomain"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF12157">
<property type="entry name" value="DUF3591"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF09247">
<property type="entry name" value="TBP-binding"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF003047">
<property type="entry name" value="TAF1_animal"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00503">
<property type="entry name" value="BROMODOMAIN"/>
</dbReference>
<dbReference type="SMART" id="SM00297">
<property type="entry name" value="BROMO"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47055">
<property type="entry name" value="SSF47055"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47370">
<property type="entry name" value="SSF47370"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00633">
<property type="entry name" value="BROMODOMAIN_1"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50014">
<property type="entry name" value="BROMODOMAIN_2"/>
<property type="match status" value="2"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0012">Acyltransferase</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0103">Bromodomain</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1023">Dystonia</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0991">Mental retardation</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0908">Parkinsonism</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Transcription initiation factor TFIID subunit 1" id="PRO_0000211215">
<location>
<begin position="1"/>
<end position="1872"/>
</location>
</feature>
<feature type="domain" description="Protein kinase 1">
<location>
<begin position="1"/>
<end position="414"/>
</location>
</feature>
<feature type="domain" description="Bromo 1" evidence="11">
<location>
<begin position="1397"/>
<end position="1467"/>
</location>
</feature>
<feature type="domain" description="Protein kinase 2">
<location>
<begin position="1425"/>
<end position="1872"/>
</location>
</feature>
<feature type="domain" description="Bromo 2" evidence="11">
<location>
<begin position="1520"/>
<end position="1590"/>
</location>
</feature>
<feature type="DNA-binding region" description="HMG box">
<location>
<begin position="1195"/>
<end position="1273"/>
</location>
</feature>
<feature type="region of interest" description="Histone acetyltransferase (HAT)">
<location>
<begin position="517"/>
<end position="976"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with ASF1A and ASF1B" evidence="15">
<location>
<begin position="1342"/>
<end position="1629"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="10">
<location>
<begin position="1351"/>
<end position="1358"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich">
<location>
<begin position="157"/>
<end position="165"/>
</location>
</feature>
<feature type="compositionally biased region" description="Asp/Glu-rich (acidic tail)">
<location>
<begin position="1627"/>
<end position="1872"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="32">
<location>
<position position="137"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="7 32">
<location>
<position position="307"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="9">
<location>
<position position="544"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="1669"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="1672"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="1778"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="1781"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="1799"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="1826"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="8">
<location>
<position position="549"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="8">
<location>
<position position="562"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform N-TAF1." id="VSP_012362" evidence="39">
<original>G</original>
<variation>GVSENGEGIILPSIIAPSSLAS</variation>
<location>
<position position="177"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2i." id="VSP_053376" evidence="40">
<original>SWPFHHPVNKKFVPDY</original>
<variation>VSCLCAKYFLAISSPS</variation>
<location>
<begin position="1525"/>
<end position="1540"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2h." id="VSP_053375" evidence="40">
<original>SWPF</original>
<variation>IITK</variation>
<location>
<begin position="1525"/>
<end position="1528"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2h." id="VSP_053377" evidence="40">
<location>
<begin position="1529"/>
<end position="1872"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2i." id="VSP_053378" evidence="40">
<location>
<begin position="1541"/>
<end position="1872"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2e." id="VSP_053379" evidence="38 40">
<original>PESQYTKT</original>
<variation>YMCTTCRT</variation>
<location>
<begin position="1585"/>
<end position="1592"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2e." id="VSP_053380" evidence="38 40">
<location>
<begin position="1593"/>
<end position="1872"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2d, isoform 2g and isoform N-TAF1." id="VSP_053381" evidence="38 39 40">
<original>Q</original>
<variation>QAK</variation>
<location>
<position position="1645"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_053382" evidence="38">
<location>
<begin position="1684"/>
<end position="1686"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2g, isoform 2a, isoform 3 and isoform 4." id="VSP_053383" evidence="38 40 41">
<original>Q</original>
<variation>QMRQGRGRLGEEDSDVDIEGYDDEEEDGKPKTPAP</variation>
<location>
<position position="1687"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2g, isoform 2a, isoform 2c, isoform 2d and isoform 3." id="VSP_053384" evidence="38 40">
<original>SYGSYEEPDPKSNTQDTSFSSIGGYEVSEEEEDEEEEEQRSGPSVLSQVHLSEDEEDSEDFHSIAGDSDLDSDE</original>
<variation>RYQ</variation>
<location>
<begin position="1799"/>
<end position="1872"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28382158." id="VAR_020678" evidence="21 37">
<original>L</original>
<variation>V</variation>
<location>
<position position="269"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35317750." id="VAR_041930" evidence="21">
<original>A</original>
<variation>G</variation>
<location>
<position position="297"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal adenocarcinoma sample; somatic mutation." id="VAR_041931" evidence="21">
<original>G</original>
<variation>D</variation>
<location>
<position position="453"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with X-linked intellectual disability; unknown pathological significance; dbSNP:rs200177996." id="VAR_077838" evidence="26">
<original>N</original>
<variation>D</variation>
<location>
<position position="472"/>
</location>
</feature>
<feature type="sequence variant" description="In MRXS33; dbSNP:rs864321630." id="VAR_076394" evidence="28">
<original>P</original>
<variation>S</variation>
<location>
<position position="575"/>
</location>
</feature>
<feature type="sequence variant" description="In a metastatic melanoma sample; somatic mutation." id="VAR_041932" evidence="21">
<original>E</original>
<variation>K</variation>
<location>
<position position="651"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung bronchoalveolar carcinoma sample; somatic mutation." id="VAR_041933" evidence="21">
<original>M</original>
<variation>I</variation>
<location>
<position position="691"/>
</location>
</feature>
<feature type="sequence variant" description="In MRXS33; dbSNP:rs864321628." id="VAR_076395" evidence="28">
<original>C</original>
<variation>R</variation>
<location>
<position position="786"/>
</location>
</feature>
<feature type="sequence variant" description="In MRXS33; dbSNP:rs864321631." id="VAR_076396" evidence="28">
<original>D</original>
<variation>H</variation>
<location>
<position position="955"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with X-linked intellectual disability; unknown pathological significance." id="VAR_077839" evidence="26">
<original>R</original>
<variation>C</variation>
<location>
<position position="1169"/>
</location>
</feature>
<feature type="sequence variant" description="In MRXS33; dbSNP:rs864321629." id="VAR_076397" evidence="28">
<original>R</original>
<variation>W</variation>
<location>
<position position="1225"/>
</location>
</feature>
<feature type="sequence variant" description="In MRXS33; dbSNP:rs864321627." id="VAR_076398" evidence="28">
<original>I</original>
<variation>T</variation>
<location>
<position position="1316"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs7050748." id="VAR_048433">
<original>V</original>
<variation>I</variation>
<location>
<position position="1383"/>
</location>
</feature>
<feature type="sequence variant" description="In MRXS33; unknown pathological significance." id="VAR_076399" evidence="28">
<original>R</original>
<variation>H</variation>
<location>
<position position="1431"/>
</location>
</feature>
<feature type="sequence variant" description="In MRXS33; unknown pathological significance." id="VAR_076400" evidence="28">
<original>N</original>
<variation>H</variation>
<location>
<position position="1496"/>
</location>
</feature>
<feature type="mutagenesis site" description="No decrease in kinase activity." evidence="35">
<original>S</original>
<variation>A</variation>
<location>
<position position="137"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces kinase activity; when associated with A-147; A-149; A-150; A-152 and A-154." evidence="35">
<original>D</original>
<variation>A</variation>
<location>
<position position="145"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces kinase activity; when associated with A-145; A-149; A-150; A-152 and A-154." evidence="35">
<original>D</original>
<variation>A</variation>
<location>
<position position="147"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces kinase activity; when associated with A-145; A-147; A-150; A-152 and A-154." evidence="35">
<original>E</original>
<variation>A</variation>
<location>
<position position="149"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces kinase activity; when associated with A-145; A-147; A-149; A-152 and A-154." evidence="35">
<original>D</original>
<variation>A</variation>
<location>
<position position="150"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces kinase activity; when associated with A-145; A-147; A-149; A-150 and A-154." evidence="35">
<original>D</original>
<variation>A</variation>
<location>
<position position="152"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces kinase activity; when associated with A-145; A-147; A-149; A-150 and A-152." evidence="35">
<original>K</original>
<variation>A</variation>
<location>
<position position="154"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces kinase activity; when associated with A-307; A-308; A-309 and A-310." evidence="35">
<original>C</original>
<variation>A</variation>
<location>
<position position="305"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces kinase activity; when associated with A-305; A-308; A-309 and A-310." evidence="35">
<original>S</original>
<variation>A</variation>
<location>
<position position="307"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces kinase activity; when associated with A-305; A-307; A-309 and A-310." evidence="35">
<original>D</original>
<variation>A</variation>
<location>
<position position="308"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces kinase activity; when associated with A-305; A-307; A-308 and A-310." evidence="35">
<original>D</original>
<variation>A</variation>
<location>
<position position="309"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces kinase activity; when associated with A-305; A-307; A-308 and A-309." evidence="35">
<original>E</original>
<variation>A</variation>
<location>
<position position="310"/>
</location>
</feature>
<feature type="mutagenesis site" description="25% decrease in histone acetylation." evidence="18">
<original>E</original>
<variation>Q</variation>
<location>
<position position="721"/>
</location>
</feature>
<feature type="mutagenesis site" description="Dramatic decrease in histone acetylation." evidence="18">
<location>
<begin position="827"/>
<end position="829"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="593"/>
<end position="596"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="600"/>
<end position="602"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="609"/>
<end position="613"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="614"/>
<end position="616"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="624"/>
<end position="626"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="627"/>
<end position="629"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="630"/>
<end position="632"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="634"/>
<end position="638"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="640"/>
<end position="655"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="656"/>
<end position="658"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="668"/>
<end position="671"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="675"/>
<end position="685"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="697"/>
<end position="704"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="708"/>
<end position="710"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="718"/>
<end position="724"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="729"/>
<end position="732"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="739"/>
<end position="756"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="761"/>
<end position="767"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="770"/>
<end position="774"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="778"/>
<end position="782"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="797"/>
<end position="817"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="820"/>
<end position="822"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="824"/>
<end position="826"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="827"/>
<end position="833"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="839"/>
<end position="847"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="850"/>
<end position="853"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="856"/>
<end position="858"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="861"/>
<end position="864"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="873"/>
<end position="879"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="882"/>
<end position="900"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="905"/>
<end position="907"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="925"/>
<end position="928"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="931"/>
<end position="942"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="947"/>
<end position="952"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="958"/>
<end position="962"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="964"/>
<end position="968"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1055"/>
<end position="1078"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1381"/>
<end position="1397"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1403"/>
<end position="1405"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1406"/>
<end position="1408"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="1411"/>
<end position="1413"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1417"/>
<end position="1420"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1427"/>
<end position="1435"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1442"/>
<end position="1460"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1462"/>
<end position="1464"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1465"/>
<end position="1483"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1485"/>
<end position="1495"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="1497"/>
<end position="1500"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1502"/>
<end position="1517"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="1518"/>
<end position="1521"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1526"/>
<end position="1528"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="1534"/>
<end position="1536"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1540"/>
<end position="1543"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1550"/>
<end position="1558"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1565"/>
<end position="1583"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1588"/>
<end position="1606"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1608"/>
<end position="1634"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3AAD"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3UV5"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4RGW"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5I29"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q80UV9"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255"/>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00035"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10759893"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11278496"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12093919"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12842904"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12928496"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15053879"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15870300"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15960975"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17273961"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2038334"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22464331"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22711989"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25412659"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25644381"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26365797"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26637982"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27007846"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7680771"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8450888"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8625415"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8647434"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8649420"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9660973"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9858607"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source ref="5"/>
</evidence>
<evidence key="38" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="12928496"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="17273961"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="17952504"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000303">
<source ref="7"/>
</evidence>
<evidence key="42" type="ECO:0000305"/>
<sequence length="1872" mass="212677" checksum="93BE3D181A72ABEB" modified="1992-05-01" version="2">
MGPGCDLLLRTAATITAAAIMSDTDSDEDSAGGGPFSLAGFLFGNINGAGQLEGESVLDD
ECKKHLAGLGALGLGSLITELTANEELTGTDGALVNDEGWVRSTEDAVDYSDINEVAEDE
SRRYQQTMGSLQPLCHSDYDEDDYDADCEDIDCKLMPPPPPPPGPMKKDKDQDSITGEKV
DFSSSSDSESEMGPQEATQAESEDGKLTLPLAGIMQHDATKLLPSVTELFPEFRPGKVLR
FLRLFGPGKNVPSVWRSARRKRKKKHRELIQEEQIQEVECSVESEVSQKSLWNYDYAPPP
PPEQCLSDDEITMMAPVESKFSQSTGDIDKVTDTKPRVAEWRYGPARLWYDMLGVPEDGS
GFDYGFKLRKTEHEPVIKSRMIEEFRKLEENNGTDLLADENFLMVTQLHWEDDIIWDGED
VKHKGTKPQRASLAGWLPSSMTRNAMAYNVQQGFAATLDDDKPWYSIFPIDNEDLVYGRW
EDNIIWDAQAMPRLLEPPVLTLDPNDENLILEIPDEKEEATSNSPSKESKKESSLKKSRI
LLGKTGVIKEEPQQNMSQPEVKDPWNLSNDEYYYPKQQGLRGTFGGNIIQHSIPAVELRQ
PFFPTHMGPIKLRQFHRPPLKKYSFGALSQPGPHSVQPLLKHIKKKAKMREQERQASGGG
EMFFMRTPQDLTGKDGDLILAEYSEENGPLMMQVGMATKIKNYYKRKPGKDPGAPDCKYG
ETVYCHTSPFLGSLHPGQLLQAFENNLFRAPIYLHKMPETDFLIIRTRQGYYIRELVDIF
VVGQQCPLFEVPGPNSKRANTHIRDFLQVFIYRLFWKSKDRPRRIRMEDIKKAFPSHSES
SIRKRLKLCADFKRTGMDSNWWVLKSDFRLPTEEEIRAMVSPEQCCAYYSMIAAEQRLKD
AGYGEKSFFAPEEENEEDFQMKIDDEVRTAPWNTTRAFIAAMKGKCLLEVTGVADPTGCG
EGFSYVKIPNKPTQQKDDKEPQPVKKTVTGTDADLRRLSLKNAKQLLRKFGVPEEEIKKL
SRWEVIDVVRTMSTEQARSGEGPMSKFARGSRFSVAEHQERYKEECQRIFDLQNKVLSST
EVLSTDTDSSSAEDSDFEEMGKNIENMLQNKKTSSQLSREREEQERKELQRMLLAAGSAA
SGNNHRDDDTASVTSLNSSATGRCLKIYRTFRDEEGKEYVRCETVRKPAVIDAYVRIRTT
KDEEFIRKFALFDEQHREEMRKERRRIQEQLRRLKRNQEKEKLKGPPEKKPKKMKERPDL
KLKCGACGAIGHMRTNKFCPLYYQTNAPPSNPVAMTEEQEEELEKTVIHNDNEELIKVEG
TKIVLGKQLIESADEVRRKSLVLKFPKQQLPPKKKRRVGTTVHCDYLNRPHKSIHRRRTD
PMVTLSSILESIINDMRDLPNTYPFHTPVNAKVVKDYYKIITRPMDLQTLRENVRKRLYP
SREEFREHLELIVKNSATYNGPKHSLTQISQSMLDLCDEKLKEKEDKLARLEKAINPLLD
DDDQVAFSFILDNIVTQKMMAVPDSWPFHHPVNKKFVPDYYKVIVNPMDLETIRKNISKH
KYQSRESFLDDVNLILANSVKYNGPESQYTKTAQEIVNVCYQTLTEYDEHLTQLEKDICT
AKEAALEEAELESLDPMTPGPYTPQPPDLYDTNTSLSMSRDASVFQDESNMSVLDIPSAT
PEKQVTQEGEDGDGDLADEEEGTVQQPQASVLYEDLLMSEGEDDEEDAGSDEEGDNPFSA
IQLSESGSDSDVGSGGIRPKQPRMLQENTRMDMENEESMMSYEGDGGEASHGLEDSNISY
GSYEEPDPKSNTQDTSFSSIGGYEVSEEEEDEEEEEQRSGPSVLSQVHLSEDEEDSEDFH
SIAGDSDLDSDE
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>